<List><item><source>MED</source><extId>26578958</extId><pmcid>PMC4624855</pmcid><annotations><annotation><prefix>o ranibizumab (PDB: </prefix><exact>1CZ8</exact><postfix>) (Chen et al., 1999</postfix><tags><tag><name>1CZ8</name><uri>http://identifiers.org/pdb/1CZ8</uri></tag></tags><id>http://europepmc.org/articles/PMC4624855#europepmc-c03a8ae1aaf2b6edba0f00e3e944ac7f</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>b-bevacizumab (PDB: </prefix><exact>1BJ1</exact><postfix>) (Muller et al., 19</postfix><tags><tag><name>1BJ1</name><uri>http://identifiers.org/pdb/1BJ1</uri></tag></tags><id>http://europepmc.org/articles/PMC4624855#europepmc-6935ec33335381026c71a7e79d97dad2</id><type>Accession Numbers</type><section>Introduction (http://purl.org/orb/Introduction)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>f bevacizumab (PDB: </prefix><exact>1BJ1</exact><postfix>) and ranibizumab (P</postfix><tags><tag><name>1BJ1</name><uri>http://identifiers.org/pdb/1BJ1</uri></tag></tags><id>http://europepmc.org/articles/PMC4624855#europepmc-e55090ee7272bda7a2528245f832f7ed</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>d ranibizumab (PDB: </prefix><exact>1CZ8</exact><postfix>) in complex with th</postfix><tags><tag><name>1CZ8</name><uri>http://identifiers.org/pdb/1CZ8</uri></tag></tags><id>http://europepmc.org/articles/PMC4624855#europepmc-7cc9b3efa5199ce62de2848a85efac2d</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>f VEGFR2 in complex with VEGFC (PDB: </prefix><exact>2X1W</exact><postfix>). </postfix><tags><tag><name>2X1W</name><uri>http://identifiers.org/pdb/2X1W</uri></tag></tags><id>http://europepmc.org/articles/PMC4624855#europepmc-fc640474b82de32f89f45e227e9206af</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>cture of VEGFA bound to ranibizumab (</prefix><exact>1CZ8</exact><postfix>). </postfix><tags><tag><name>1CZ8</name><uri>http://identifiers.org/pdb/1CZ8</uri></tag></tags><id>http://europepmc.org/articles/PMC4624855#europepmc-7d5bab8413b2d4faeffdcc302b3d753c</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>rimposition on PDB: </prefix><exact>1BJ1</exact><postfix> and PDB: 1CZ8 x-ray</postfix><tags><tag><name>1BJ1</name><uri>http://identifiers.org/pdb/1BJ1</uri></tag></tags><id>http://europepmc.org/articles/PMC4624855#europepmc-aa31e8c1da57b49a5ed134a505519267</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix> PDB: 1BJ1 and PDB: </prefix><exact>1CZ8</exact><postfix> x-ray structures, r</postfix><tags><tag><name>1CZ8</name><uri>http://identifiers.org/pdb/1CZ8</uri></tag></tags><id>http://europepmc.org/articles/PMC4624855#europepmc-1f7fc92eb7a2130c01b539c27950603f</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>ion on the corresponding template PDB:</prefix><exact>2X1W</exact><postfix>. </postfix><tags><tag><name>2X1W</name><uri>http://identifiers.org/pdb/2X1W</uri></tag></tags><id>http://europepmc.org/articles/PMC4624855#europepmc-888d6defba9f78a35382fa4f831cf53d</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>GFC and VEGFA (PDB: </prefix><exact>2X1W</exact><postfix> and PDB: 3V2A, resp</postfix><tags><tag><name>2X1W</name><uri>http://identifiers.org/pdb/2X1W</uri></tag></tags><id>http://europepmc.org/articles/PMC4624855#europepmc-c376e89d5463259dc8aa87350cf18829</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation><annotation><prefix>(PDB: 2X1W and PDB: </prefix><exact>3V2A</exact><postfix>, respectively; Supp</postfix><tags><tag><name>3V2A</name><uri>http://identifiers.org/pdb/3V2A</uri></tag></tags><id>http://europepmc.org/articles/PMC4624855#europepmc-171f58ec92479558adf1268038a01188</id><type>Accession Numbers</type><section>Results (http://purl.org/orb/Results)</section><provider>Europe PMC</provider><subType>PDBe</subType></annotation></annotations></item></List>